Harrow, Inc. (HROW) Financials
HROW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 311.8 million | 241.8 million |
2023-09-30 | 286.1 million | 210.7 million |
2023-06-30 | 224.0 million | 201.9 million |
2023-03-31 | 217.5 million | 196.0 million |
HROW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 8.5 million | 4.2 million |
2023-09-30 | -21.3 million | 4.5 million |
2023-06-30 | 3.3 million | 5.4 million |
2023-03-31 | -139.2 million | 1.6 million |
HROW Net Income
No data available :(
HROW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 82.8 million | - | 7.3 million |
2023-09-30 | 65.6 million | - | 7.5 million |
2023-06-30 | 22.8 million | 169.7 million | 7.7 million |
2023-03-31 | 19.2 million | 168.9 million | 7.9 million |
HROW Shares Outstanding
HROW Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 203000 | 3.3 million | 26.2 million | - |
2023-09-30 | 20.1 million | 1.4 million | 21.0 million | - |
2023-06-30 | 1.2 million | 1.2 million | 20.0 million | - |
2023-03-31 | 131.0 million | 734000 | 15.9 million | - |
HROW Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 36.4 million | 11.3 million |
2023-09-30 | 34.3 million | 10.1 million |
2023-06-30 | 33.5 million | 10.0 million |
2023-03-31 | 26.1 million | 8.3 million |
HROW
Price: $10.38
52 week price:
Earnings Per Share: -0.75 USD
P/E Ratio: -26.11
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 114053
Market Capitalization: 447.7 million